Based on these reports, similar changes in skin small vessel walls, with increased tissue expression of anti-Ro and anti-La antibodies, could lead to the clinical manifestations of cutaneous vasculitis in pSS patients. This evidence concerns the gene CALR and cutaneous vasculitis.